ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658103; 2) Community: the network communities that were significantly associated with the response to NSC 658103; 3) Molecule: the relationships between components within communities and NSC 658103; 4) MDR: the compounds that were significantly associated with the NSC 658103.

NSC Compound Enrichment Correlation
NSC 53327 Null 0.0454469012959173 0.34696717
NSC 603831 Acteoside 0.0454469012959173 0.45314811
NSC 609699 Topotecan hydrochloride 0.0454469012959173 0.5974197
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0454469012959173 0.23784501
NSC 639186 Raltitrexed 0.0454469012959173 0.52486753
NSC 640499 2,2':6',2"-Terpyridine, 4'-[4-(2-hydroxyethoxy)phenyl]- 0.0454469012959173 0.34110597
NSC 651853 Null 0.0454469012959173 0.42817902
NSC 657282 Null 0.0454469012959173 0.48020739
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0459335986102865 0.41278036
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0459335986102865 0.12487325
Total:83  Current:74    [First] [Prev] [Next] [Last]